|
Press Releases |
|
|
|
Wednesday, February 1, 2023 |
|
Ocumension Therapeutics Announces Its Patient Enrollment Completed In The Phase III Clinical Trail Of OT-101 In China |
Ocumension Therapeutics ("Ocumension" or the "Company", together with its subsidiaries, collectively the "Group", stock code: 1477), a China-based ophthalmic pharmaceutical platform company, announces that OT-101 (0.01% atropine sulfate eye drop) more info >> |
|
Monday, January 30, 2023 |
|
欧康维视生物分别任命阮添士先生及王冲先生为首席财务官及投资者关系负责人 |
欧康维视生物(1477.HK)欣然宣布,已任命阮添士先生及王冲先生为首席财务官及投资者关系负责人。 more info >> |
|
歐康維視生物分別任命阮添士先生及王沖先生為首席財務官及投資者關係負責人 |
歐康維視生物(1477.HK)欣然宣佈,已任命阮添士先生及王沖先生為首席財務官及投資者關係負責人。 more info >> |
|
Ocumension Therapeutics Appoints Mr. Tim RUAN and Mr. WANG Chong as Chief Financial Officer and Head of Investor Relations respectively |
Ocumension Therapeutics (1477.HK) is pleased to announce that Mr. Tim RUAN and Mr. WANG Chong have been appointed as Chief Financial Officer and Head of Investor Relations respectively of the Group. more info >> |
|
Saturday, March 20, 2021 |
|
欧康维视 (1477.HK) 公布2020年全年业绩 |
中国眼科医药平台公司 — 欧康维视生物 (「欧康维视」或「公司」,连同其附属公司「集团」)(股份代号:1477.HK),今天公布截至2020年12月31日止年度全年业绩。 more info >> |
|
歐康維視 (1477.HK) 公佈2020年全年業績 |
中國眼科醫藥平台公司 — 歐康維視生物 (「歐康維視」或「公司」,連同其附屬公司「集團」)(股份代號:1477.HK),今天公佈截至2020年12月31日止年度全年業績。 more info >> |
|
Ocumension Therapeutics (1477.HK) Announces 2020 Annual Results |
The Chinese ophthalmology platform company, Ocumension Therapeutics ("Ocumension" or the "Company", together with its subsidiaries, the "Group" ), (stock code: 1477.HK), announced its annual results for the year ended 31 December 2020 today. more info >> |
|
Tuesday, November 17, 2020 |
|
欧康维视生物荣获格隆汇2020大中华区最佳上市公司 -「最受关注IPO」大奖 |
2020年11月17日, 由格隆汇主办的「2020大中华区最佳上市公司」的评选结果已于11月16日揭晓,欧康维视(1477.HK)凭借在上市前后的优秀表现,获得资本市场的高度认可,成功荣获「最受关注IPO」大奖,并由公司董事会秘书季云女士出席颁奖礼领奖。 more info >> |
|
歐康維視生物榮獲格隆匯2020大中華區最佳上市公司 -「最受關注IPO」大獎 |
2020年11月17日, 由格隆匯主辦的「2020大中華區最佳上市公司」的評選結果已於11月16日揭曉,歐康維視(1477.HK)憑藉在上市前後的優秀表現,獲得資本市場的高度認可,成功榮獲「最受關注IPO」大獎,並由公司董事會秘書季雲女士出席頒獎禮領獎。 more info >> |
|
Thursday, August 27, 2020 |
|
欧康维视中报巨亏起底 这家眼科新贵手握大把现金,其实不差钱? |
新股欧康维视生物 (1477) 昨日公布了2020年上半年业绩,收益为195万元 (人民币‧下同) ,但受人瞩目的是公司期内亏损及全面开支总额为17.42亿元。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
First Quarterly Profit, High-Quality Platform Growth, NaaS Technology Accelerates Ecosystem Development
Nov 22, 2024 23:22 HKT/SGT
|
|
|
CleverTap Recognized as a 'Strong Performer' in the Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 22, 2024 22:42 JST
|
|
|
Tat Hong Equipment Service Co., Ltd. Announces 2024/25 Interim Results
Nov 22, 2024 19:56 HKT/SGT
|
|
|
达丰设备服务有限公司 公布2024/25中期业绩
Nov 22, 2024 19:35 HKT/SGT
|
|
|
達豐設備服務有限公司 公佈2024/25中期業績
Nov 22, 2024 19:18 HKT/SGT
|
|
|
透雲生物萊茵衣藻獲國家衛健委新用途許可
Nov 22, 2024 14:42 HKT/SGT
|
|
|
透云生物莱茵衣藻获国家卫健委新用途许可
Nov 22, 2024 14:41 HKT/SGT
|
|
|
Daeshin MC Co., Ltd. Unveils Its Clean Solutions Creating Pleasant Indoor Environments from Industrial Sites to Public Facilities
Nov 22, 2024 12:00: JST
|
|
|
Daeshin MC Co., Ltd.は、産業現場から公共施設まで快適な室内環境を作り出すクリーンソリューションを発表
Nov 22, 2024 12:00: JST
|
|
|
三菱重工、新たな防衛輸送用「機動舟艇」に搭載するウォータージェット推進装置の供給へ
Nov 22, 2024 11:45: JST
|
|
|
Daeshin MC Co., Ltd. Unveils Its Clean Solutions Creating Pleasant Indoor Environments from Industrial Sites to Public Facilities
Nov 22, 2024 11:00 HKT/SGT
|
|
|
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025
Nov 22, 2024 11:00 JST
|
|
|
Jacobson Pharma Announces FY2025 Interim Results
Nov 22, 2024 10:00 HKT/SGT
|
|
|
雅各臣公佈二零二五財年中期業績 持續經營業務溢利飈升44.2%
Nov 22, 2024 10:00 HKT/SGT
|
|
|
アレス・マネジメント、東京オフィス開設でアジア事業を拡充
Nov 22, 2024 09:00: JST
|
|
|
|
More News >> |
|
|
|
|
|